MedPath

Appropriate Dose of Initial Heparin Administration without Glycoprotein Inhibitor on Catheter Interventio

Not Applicable
Conditions
Coronary/peripheral artery disease planned with catheter intervention
Registration Number
JPRN-UMIN000014180
Lead Sponsor
ishiarai Heart Center Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

i) Emergent/urgent intervention ii) Patients with malignant neoplasm whose life expectancies of less than 6 months iii) Patients with active bleeding or embolic complications iv) Patients with HIT(Heparin-Induced Thrombocytopenia) v) Unsuitable patients for this trial judged by doctor-in-charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
i) Time achieved with ACT>250 seconds ii) Bleeding and embolic complications up to 30 days after the procedure
Secondary Outcome Measures
NameTimeMethod
i) Frequency of heparin addition during procedure ii) Change of WBC/RBC/Platelets between before and after the procedure iii) All-cause death, MACE
© Copyright 2025. All Rights Reserved by MedPath